These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

406 related items for PubMed ID: 8228826

  • 1. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion.
    Lin H, Bolling SF, Linsley PS, Wei RQ, Gordon D, Thompson CB, Turka LA.
    J Exp Med; 1993 Nov 01; 178(5):1801-6. PubMed ID: 8228826
    [Abstract] [Full Text] [Related]

  • 2. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2.
    Sayegh MH, Akalin E, Hancock WW, Russell ME, Carpenter CB, Linsley PS, Turka LA.
    J Exp Med; 1995 May 01; 181(5):1869-74. PubMed ID: 7536798
    [Abstract] [Full Text] [Related]

  • 3. Preventing allograft rejection with CTLA4IG: effect of donor-specific transfusion route or timing.
    Bolling SF, Lin H, Wei RQ, Turka LA.
    J Heart Lung Transplant; 1996 Sep 01; 15(9):928-35. PubMed ID: 8889989
    [Abstract] [Full Text] [Related]

  • 4. Tolerance to cardiac allografts via local and systemic mechanisms after adenovirus-mediated CTLA4Ig expression.
    Guillot C, Mathieu P, Coathalem H, Le Mauff B, Castro MG, Tesson L, Usal C, Laumonier T, Brouard S, Soulillou JP, Lowenstein PR, Cuturi MC, Anegon I.
    J Immunol; 2000 May 15; 164(10):5258-68. PubMed ID: 10799887
    [Abstract] [Full Text] [Related]

  • 5. Donor antigen is necessary for the prevention of chronic rejection in CTLA4Ig-treated murine cardiac allograft recipients.
    Sayegh MH, Zheng XG, Magee C, Hancock WW, Turka LA.
    Transplantation; 1997 Dec 27; 64(12):1646-50. PubMed ID: 9422396
    [Abstract] [Full Text] [Related]

  • 6. CD28 blockade alters cytokine mRNA profiles in cardiac transplantation.
    Lin H, Wei RQ, Goodman RE, Bolling SF.
    Surgery; 1997 Aug 27; 122(2):129-37. PubMed ID: 9288115
    [Abstract] [Full Text] [Related]

  • 7. CD28-B7 T-cell co-stimulatory blockade potentiates the effects of intrathymic immunomodulation in sensitized graft recipients.
    Stadlbauer TH, Schaub M, Korom S, Onodera K, Sayegh MH, Kupiec-Weglinski JW.
    Transplantation; 1997 Dec 27; 64(12):1816-22. PubMed ID: 9422425
    [Abstract] [Full Text] [Related]

  • 8. Cardiac allograft tolerance induced by intra-arterial infusion of recombinant adenoviral CTLA4Ig.
    Yang Z, Rostami S, Koeberlein B, Barker CF, Naji A.
    Transplantation; 1999 Jun 27; 67(12):1517-23. PubMed ID: 10401757
    [Abstract] [Full Text] [Related]

  • 9. Blockade of multiple costimulatory receptors induces hyporesponsiveness: inhibition of CD2 plus CD28 pathways.
    Woodward JE, Qin L, Chavin KD, Lin J, Tono T, Ding Y, Linsley PS, Bromberg JS, Baliga P.
    Transplantation; 1996 Oct 15; 62(7):1011-8. PubMed ID: 8878397
    [Abstract] [Full Text] [Related]

  • 10. CD28-B7 T cell costimulatory blockade by CTLA4Ig in sensitized rat recipients: induction of transplantation tolerance in association with depressed cell-mediated and humoral immune responses.
    Onodera K, Chandraker A, Schaub M, Stadlbauer TH, Korom S, Peach R, Linsley PS, Sayegh MH, Kupiec-Weglinski JW.
    J Immunol; 1997 Aug 15; 159(4):1711-7. PubMed ID: 9257832
    [Abstract] [Full Text] [Related]

  • 11. Distinct tolerance pathways in sensitized allograft recipients after selective blockade of activation signal 1 or signal 2.
    Onodera K, Chandraker A, Volk HD, Ritter T, Lehmann M, Kato H, Sayegh MH, Kupiec-Weglinski JW.
    Transplantation; 1999 Jul 27; 68(2):288-93. PubMed ID: 10440403
    [Abstract] [Full Text] [Related]

  • 12. Long-term acceptance of rat cardiac allografts on the basis of adenovirus mediated CD40Ig plus CTLA4Ig gene therapies.
    Yamashita K, Masunaga T, Yanagida N, Takehara M, Hashimoto T, Kobayashi T, Echizenya H, Hua N, Fujita M, Murakami M, Furukawa H, Uede T, Todo S.
    Transplantation; 2003 Oct 15; 76(7):1089-96. PubMed ID: 14557758
    [Abstract] [Full Text] [Related]

  • 13. T-cell costimulatory blockade in experimental chronic cardiac allograft rejection: effects of cyclosporine and donor antigen.
    Chandraker A, Russell ME, Glysing-Jensen T, Willett TA, Sayegh MH.
    Transplantation; 1997 Apr 27; 63(8):1053-8. PubMed ID: 9133464
    [Abstract] [Full Text] [Related]

  • 14. Prevention of acute lung allograft rejection in rat by CTLA4Ig.
    Shiraishi T, Yasunami Y, Takehara M, Uede T, Kawahara K, Shirakusa T.
    Am J Transplant; 2002 Mar 27; 2(3):223-8. PubMed ID: 12096784
    [Abstract] [Full Text] [Related]

  • 15. Toward novel antirejection strategies: in vivo immunosuppressive properties of CTLA4Ig.
    Perico N, Imberti O, Bontempelli M, Remuzzi G.
    Kidney Int; 1995 Jan 27; 47(1):241-6. PubMed ID: 7731152
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Simultaneous administration of a low-dose mixture of donor bone marrow cells and splenocytes plus adenovirus containing the CTLA4Ig gene result in stable mixed chimerism and long-term survival of cardiac allograft in rats.
    Jin Y, Zhang Q, Hao J, Gao X, Guo Y, Xie S.
    Immunology; 2003 Oct 27; 110(2):275-86. PubMed ID: 14511242
    [Abstract] [Full Text] [Related]

  • 19. Pattern of alloimmune response in second same donor allografts after induction of tolerance using CTLA4Ig.
    Olthoff KM, Gelman AE, Zamir GA, Debonera F, Krasinkas AM, Shen X, Gao F, Shaked A.
    Transplantation; 2001 Dec 27; 72(12):1952-6. PubMed ID: 11773895
    [Abstract] [Full Text] [Related]

  • 20. Immunomodulation with intrathymic injection of donor splenocytes followed by CTLA4Ig therapy prolongs small intestinal allograft survival.
    Greenstein SM, Sun S, Schechner RS, Tellis VA.
    Transplant Proc; 1997 Dec 27; 29(1-2):1065-6. PubMed ID: 9123201
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.